Regulation of liver innate immunnity in human hepatocellular carcinoma
Project/Area Number |
24590973
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Gastroenterology
|
Research Institution | Osaka University |
Principal Investigator |
TATSUMI Tomohide 大阪大学, 医学(系)研究科(研究院), 助教 (20397699)
|
Co-Investigator(Kenkyū-buntansha) |
MIYAGI Takuya 大阪大学, 大学院医学系研究科, 助教 (80532986)
|
Research Collaborator |
NAWA Takatoshi
AONO Satoshi
|
Project Period (FY) |
2012-04-01 – 2015-03-31
|
Project Status |
Completed (Fiscal Year 2014)
|
Budget Amount *help |
¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2014: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2013: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2012: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Keywords | 肝細胞癌 / C型肝炎ウイルス / 抗癌剤 / 先天免疫 / 細胞周期 / 肝癌幹細胞 / 低酸素 / 抗がん剤 |
Outline of Final Research Achievements |
The aim of this study is to investigate the cell death of hepatitis C virus (HCV) infected hepatocellular carcinoma (HCC) cells. HCV-infected HCC cells were more resistant to epirubicin and sorafenib than non-infected HCC cells. HCV-infected HCC cells exhibited anti-apoptotic and higher expression of ATP-binding cassette drug transporters. HCV infection resulted in increasing the characteristics of cancer stem cell of HCC. Cell cycle analysis revealed the increase of sub-population of G0/G1 phase in HCV-infected HCC cells. HCV eradication by interferon-alpha treatment resulted in improvement of the efficacy of anti-cancer drug by changing the anti-apoptotic characteristics. These results suggested that eradication of HCV should be required in the treatment of HCC.
|
Report
(4 results)
Research Products
(51 results)
-
[Journal Article] Risk factors for hepatocellular carcinoma in hepatitis C patients with normal ALT treated with pegylated interferon and ribavirin2014
Author(s)
Harada N, Hiramatsu N, Oze T, Morishita N, Yamada R, Hikita H, Miyazaki M, Yakushijin T, Miyagi T, Yoshida Y, Tatsumi T, Kanto A, Kasahara A, Oshita M, Mita E, Hagiwara H, Inui Y, Katayama K, Shinji Tamura, Yoshihara H, Imai Y, Inoue A, Hayashi N, Takehara T
-
Journal Title
J Viral Hepat
Volume: 21
Issue: 5
Pages: 357-365
DOI
Related Report
Peer Reviewed / Acknowledgement Compliant
-
-
[Journal Article] Incidence of hepatocellular carcinoma in HCV-infected patients with normal alanine aminotransferase levels categorized by Japanese treatment guidelines2013
Author(s)
Harada N, Hiramatsu N, Oze T, Yamada R, Kurokawa M, Miyazaki M, Yakushijin T, Miyagi T, Tatsumi T, Kiso S, Kanto T, Kasahara A, Oshita M, Mita E, Hagiwara H, Inui Y, Katayama K, Tamura S, Yoshihara H, Imai Y, Inoue A, Hayashi N, Takehara T
-
Journal Title
J Gastroenterol
Volume: 48
Issue: 4
Pages: 535-43
DOI
NAID
Related Report
Peer Reviewed
-
[Journal Article] The Bcl-2 homology 3 (BH3)-only proteins Bim and Bid are functionally active and restrained by anti-apoptotic B-cell CLL/lymphoma 2 (Bcl-2) family proteins in healthy liver.2013
Author(s)
[1] Kodama T, Hikita H, Kawaguchi T, Saito Y, Tanaka S, Shigekawa M, Shimizu S, Li W, Miyagi T, Kanto T, Hiramatsu N, Tatsumi T, Takehara T.
-
Journal Title
J. Biol. Chem.
Volume: 288
Issue: 42
Pages: 30009-30018
DOI
Related Report
Peer Reviewed
-
[Journal Article] Valine, the branched-chain amino acid, suppresses hepatitis C virus RNA replication but promotes infectious particle formation2013
Author(s)
Ishida H, Kato T, Takehana K, Tatsumi T, Hosui A, Nawa T, Kodama T, Shimizu S, Hikita H, Hiramatsu N, Kanto T, Hayashi N, Takehara T
-
Journal Title
Biochem Biophys Res Commun
Volume: 437
Issue: 1
Pages: 127-33
DOI
Related Report
Peer Reviewed
-
[Journal Article] The combination therapy of α-galactosylceramide and 5-fluorouracil showed antitumor effect synergistically against liver tumor in mice2013
Author(s)
Aketa H, Tatsumi T, Kohga K, Tsunematsu H, Aono S, Shimizu S, Kodama T, Nawa T, Shigekawa M, Hikita H, Sakamori R, Hosui A, Miyagi T, Hiramatsu N, Kanto T, Hayashi N, Takehara T
-
Journal Title
Int J Cancer
Volume: 133
Issue: 5
Pages: 1126-34
DOI
Related Report
Peer Reviewed
-
-
-
-
[Journal Article] Mcl-1 and Bcl-xL regulate Bak/Bax-dependent apoptosis of the megakaryocytic lineage at multistages.2012
Author(s)
Kodama T, Hikita H, Kawaguchi T, Shigekawa M, Shimizu S, Hayashi Y, Li W, Miyagi T, Hosui A, Tatsumi T, Kanto T, Hiramatsu N, Kiyomizu K, Tadokoro S, Tomiyama Y, Hayashi N, Takehara T.
-
Journal Title
Cell Death Differ.
Volume: 19(11)
Issue: 11
Pages: 1856-1869
DOI
Related Report
Peer Reviewed
-
-
-
[Presentation] Involvement of hepatitis C virus infection in the regulation of chemo-sensitivity of hepatocellular carcinoma cells2014
Author(s)
Nawa T, Tatsumi T, Nishio A, Tawara S, Onishi Y, Aono S, Hayato Hikita H, Sakamori R, Miyagi T, Hiramatsu N, Takehara T
Organizer
The American Association fore Study of Liver Diseases
Place of Presentation
米国ボストン市
Year and Date
2014-11-07 – 2014-11-11
Related Report
-
-
-
-
-
-
-
[Presentation] Hepatitis C virus infection reduces chemo-sensitivity of the hepatocellular carcinoma cells through enhancing cancer stem cell characters.2013
Author(s)
Takatoshi Nawa, Tomohide Tatsumi, Akira Nishio, Seiichi Tawara, Yoshiki Ohnishi, Satoshi Aono, Satoshi Shimizu, Hayato Hikita, Ryotaro Sakamori, Takuya Miyagi, Naoki Hiramatsu, Tetsuo Takehara
Organizer
American Association of the Study of Liver Disease 64th
Place of Presentation
米国ワシントンDC
Related Report
-
-
[Presentation] A novel hepato-proliferative effect of carbamazepine during liver regeneration2013
Author(s)
Tsukasa Kawaguchi, Takahiro Kodama, Satoshi Tanaka, Kaori Mukai, Satoshi Aono, Minoru Shigekawa, Satoshi Shimizu, Hayato Hikita, Wei Li, Takuya Miyagi, Naoki Hiramatsu, Tomohide Tatsumi, Tetsuo Takehara
Organizer
American Association of the Study of Liver Disease 64th
Place of Presentation
米国ワシントンDC
Related Report
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-